| Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States A Dasari, C Shen, D Halperin, B Zhao, S Zhou, Y Xu, T Shih, JC Yao JAMA oncology 3 (10), 1335-1342, 2017 | 3378 | 2017 |
| A population-based study of cardiovascular disease mortality risk in US cancer patients KM Sturgeon, L Deng, SM Bluethmann, S Zhou, DM Trifiletti, C Jiang, ... European heart journal 40 (48), 3889-3897, 2019 | 806 | 2019 |
| Treatment-related adverse events of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis Y Wang, S Zhou, F Yang, X Qi, X Wang, X Guan, C Shen, N Duma, ... JAMA oncology 5 (7), 1008-1019, 2019 | 770 | 2019 |
| PD-L1 expression and prognostic impact in glioblastoma EK Nduom, J Wei, NK Yaghi, N Huang, LY Kong, K Gabrusiewicz, X Ling, ... Neuro-oncology 18 (2), 195-205, 2015 | 627 | 2015 |
| Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis DA Berry, S Zhou, H Higley, L Mukundan, S Fu, GH Reaman, BL Wood, ... JAMA oncology 3 (7), e170580-e170580, 2017 | 541 | 2017 |
| Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype K Gabrusiewicz, B Rodriguez, J Wei, Y Hashimoto, LM Healy, SN Maiti, ... JCI insight 1 (2), e85841, 2016 | 456 | 2016 |
| Long-acting somatostatin analog therapy of acromegaly: a meta-analysis PU Freda, L Katznelson, AJ Van Der Lely, CM Reyes, S Zhao, ... The journal of clinical endocrinology & metabolism 90 (8), 4465-4473, 2005 | 446 | 2005 |
| Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study DM Halperin, C Shen, A Dasari, Y Xu, Y Chu, S Zhou, YCT Shih, JC Yao The Lancet Oncology 18 (4), 525-534, 2017 | 399 | 2017 |
| Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy TR Hodges, M Ott, J Xiu, Z Gatalica, J Swensen, S Zhou, JT Huse, ... Neuro-oncology 19 (8), 1047-1057, 2017 | 397 | 2017 |
| Association of measurable residual disease with survival outcomes in patients with acute myeloid leukemia: a systematic review and meta-analysis NJ Short, S Zhou, C Fu, DA Berry, RB Walter, SD Freeman, CS Hourigan, ... JAMA oncology 6 (12), 1890-1899, 2020 | 319 | 2020 |
| Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target J Wei, A Marisetty, B Schrand, K Gabrusiewicz, Y Hashimoto, M Ott, ... The Journal of clinical investigation 129 (1), 137-149, 2019 | 318 | 2019 |
| Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes K Gabrusiewicz, X Li, J Wei, Y Hashimoto, AL Marisetty, M Ott, F Wang, ... Oncoimmunology 7 (4), e1412909, 2018 | 304 | 2018 |
| Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma L Zhang, Y Yao, S Zhang, Y Liu, H Guo, M Ahmed, T Bell, H Zhang, G Han, ... Science translational medicine 11 (491), eaau1167, 2019 | 242 | 2019 |
| Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer DV Fried, SL Tucker, S Zhou, Z Liao, O Mawlawi, G Ibbott, LE Court International Journal of Radiation Oncology* Biology* Physics 90 (4), 834-842, 2014 | 222 | 2014 |
| MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints J Wei, EK Nduom, LY Kong, Y Hashimoto, S Xu, K Gabrusiewicz, X Ling, ... Neuro-oncology 18 (5), 639-648, 2016 | 193 | 2016 |
| Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages J De Groot, M Penas-Prado, K Alfaro-Munoz, K Hunter, BL Pei, B O’Brien, ... Neuro-oncology 22 (4), 539-549, 2020 | 152 | 2020 |
| EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression A Satelli, I Batth, Z Brownlee, A Mitra, S Zhou, H Noh, CR Rojas, H Li, ... Oncotarget 8 (30), 49329, 2017 | 149 | 2017 |
| Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies ST Garber, Y Hashimoto, SP Weathers, J Xiu, Z Gatalica, RGW Verhaak, ... Neuro-oncology 18 (10), 1357-1366, 2016 | 145 | 2016 |
| Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma Y Oki, D Buglio, M Fanale, L Fayad, A Copeland, J Romaguera, LW Kwak, ... Clinical cancer research 19 (24), 6882-6890, 2013 | 132 | 2013 |
| Comprehensive investigation on controlling for CT imaging variabilities in radiomics studies RB Ger, S Zhou, PCM Chi, HJ Lee, RR Layman, AK Jones, DL Goff, ... Scientific reports 8 (1), 13047, 2018 | 111 | 2018 |
Amy HeimbergerNorthwestern UniversityOverená e-mailová adresa na: northwestern.edu
